PATENT CLAIM ANALYSIS

Application Number: 16009490
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Disclosed are compositions containing not less than 10% w/w of oroxylin A, not less than 10% w/w of baicalein and not less than 2% w/w of chrysin for use in the therapeutic management of memory impairment and cognitive dysfunction. More specifically, the invention discloses the use of abovementioned compositions for the management of cognitive impairment induced by chemotherapy and hyperglycemia.

Claim (Index 10):
The method as in  claim 9 , wherein the composition preferably comprises 10%-15% w/w of oroxylin A, 10%-25% w/w of baicalein and 2%-10% w/w of chrysin.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.76316
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15805320', '13377502', '14976986', '14303622', '15344417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7558174599006392
- 35 USC 102 Novelty (BERT): 0.524381739266119
- Combined Prediction Score: 0.7326738878371871
- Mean Citation Score: 235.570868
- Max Citation Score: 319.27374
- Similarity Product: 218.46703299290297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test